Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Charlotte Laurent"'
Autor:
Dominique Bertrand, Charlotte Laurent, Mathilde Lemoine, Ludivine Lebourg, Mélanie Hanoy, Frank Le Roy, Dorian Nezam, Diana Pruteanu, Steven Grange, Tristan De Nattes, Véronique Lemée, Dominique Guerrot, Sophie Candon
Publikováno v:
Microorganisms, Vol 12, Iss 4, p 722 (2024)
Monoclonal antibodies have been administered to kidney transplant recipients (KTRs) with a poor or non-responder status to SARS-CoV-2 vaccination. The cellular response to SARS-CoV-2 has been poorly studied in this context. We assessed the T cell res
Externí odkaz:
https://doaj.org/article/0f0064b521b44a8c91b87b43c97fab27
Autor:
Anais Romero, Charlotte Laurent, Ludivine Lebourg, Veronique Lemée, Mélanie Hanoy, Frank Le Roy, Steven Grange, Mathilde Lemoine, Dominique Guerrot, Dominique Bertrand
Publikováno v:
Viruses, Vol 16, Iss 3, p 381 (2024)
Background: Kidney transplant recipients (KTRs) are likely to develop severe COVID-19 and are less well-protected by vaccines than immunocompetent subjects. Thus, the use of neutralizing anti–SARS-CoV-2 monoclonal antibodies (mAbs) to confer a pass
Externí odkaz:
https://doaj.org/article/e18e49b10bdd4f27bdf9d70144ce1275
Autor:
Juliette Noelle, Valentin Mayet, Céline Lambert, Lionel Couzi, Bertrand Chauveau, Antoine Thierry, Laure Ecotière, Dominique Bertrand, Charlotte Laurent, Richard Lemal, Clarisse Grèze, Marine Freist, Anne-Elisabeth Heng, Paul-Olivier Rouzaire, Cyril Garrouste
Publikováno v:
Transplant International, Vol 36 (2023)
The impact of immunosuppressive therapy (IS) strategies after kidney transplant failure (KTF) on potential future new grafts is poorly established. We assessed the potential benefit of calcineurin inhibitor (CNI)-based IS maintenance throughout the d
Externí odkaz:
https://doaj.org/article/5d8ba97e257c46209186349844dac3a0
Autor:
Arsène Mekinian, Jérémie Sellam, Laure Ricard, Olivier Fain, Ariel Cohen, François Chasset, Claire de Moreuil, François Maillot, Sonia Alamowitch, Noemie Abisror, Geoffrey Urbanski, Alexis F Guedon, Charlotte Laurent, Sophie Deriaz, Grigorios Gerotziafas, Ismail Elalamy, Alexandra Audemard, Jean Jacques Boffa, Clémentine Wahl
Publikováno v:
RMD Open, Vol 9, Iss 1 (2023)
Introduction Antiphospholipid syndrome (APS) is an autoimmune disease characterised by thrombosis (arterial, venous or small vessel) or obstetrical events and persistent antiphospholipid antibodies (aPL), according to the Sydney classification criter
Externí odkaz:
https://doaj.org/article/4429afc78db94e38b19fddd4015fb455
Autor:
Arsène Mekinian, Laure Ricard, Olivier Fain, Claire de Moreuil, Eric Rondeau, Yann Nguyen, Cathererine Johanet, Charlotte Laurent, Sophie Deriaz, Grigorios Gerotziafas, Ismail Elalamy, Jean Jacques Boffa, Virginie Planche, Francois Millot
Publikováno v:
RMD Open, Vol 9, Iss 1 (2023)
Objective Antiphospholipid syndrome (APS) is defined by the association of thromboembolic and/or obstetrical clinical manifestations and the presence of antiphospholipid antibodies. The objective of our study was to evaluate the impact of the triple-
Externí odkaz:
https://doaj.org/article/2c077ad37a2a45bfac2421f3fcabfae4
Autor:
Alexis F. Guédon, Jennifer Catano, Laure Ricard, Charlotte Laurent, Claire de Moreuil, Geoffrey Urbanski, Sophie Deriaz, Grigorios Gerotziafas, Ismail Elalamy, Alexandra Audemard, Francois Chasset, Sonia Alamowitch, Jérémie Sellam, François Maillot, Jean Jacques Boffa, Ariel Cohen, Noémie Abisror, Olivier Fain, Arsène Mekinian
Publikováno v:
Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-8 (2022)
Abstract Background From this retrospective study, we aimed to (1) describe the prevalence and characteristics of non-criteria features in primary antiphospholipid syndrome (p-APS) and (2) determine their prognostic value. Methods This retrospective
Externí odkaz:
https://doaj.org/article/e0062717d1964306b19b39824dc45370
Autor:
Charlotte Laurent, Sergio Prieto-González, Pierre Belnou, Fabrice Carrat, Olivier Fain, Azeddine Dellal, Maria C. Cid, José Hernández-Rodríguez, Arsène Mekinian
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
Abstract The aim of this study was to assess the prevalence of cardiovascular risk factors in TAK, to describe the use of aspirin and statins and the risk factors associated with vascular ischemic complications and relapses. We conducted a retrospect
Externí odkaz:
https://doaj.org/article/c38fe663bfbe493b8453eccfb5a6f005
Autor:
Thomas Duflot, Charlotte Laurent, Anne Soudey, Xavier Fonrose, Mouad Hamzaoui, Michèle Iacob, Dominique Bertrand, Julie Favre, Isabelle Etienne, Clothilde Roche, David Coquerel, Maëlle Le Besnerais, Safa Louhichi, Tracy Tarlet, Dongyang Li, Valéry Brunel, Christophe Morisseau, Vincent Richard, Robinson Joannidès, Françoise Stanke-Labesque, Fabien Lamoureux, Dominique Guerrot, Jérémy Bellien
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract This study addressed the hypothesis that epoxyeicosatrienoic acids (EETs) synthesized by CYP450 and catabolized by soluble epoxide hydrolase (sEH) are involved in the maintenance of renal allograft function, either directly or through modula
Externí odkaz:
https://doaj.org/article/bdccddf5b20441ff9d36a503e8db992b
Autor:
Dominique Bertrand, MD, Mouad Hamzaoui, MD, PhD, Laurent Drouot, PhD, Julie Lamulle, MA, Mélanie Hanoy, MD, Stéphane Edet, MD, Charlotte Laurent, MD, Ludivine Lebourg, MD, Isabelle Etienne, MD, Mathilde Lemoine, MD, Frank Le Roy, MD, Dorian Nezam, MD, Eleusis Mauger, MD, Olivier Boyer, MD, PhD, Dominique Guerrot, MD, PhD, Sophie Candon, MD, PhD
Publikováno v:
Transplantation Direct, Vol 7, Iss 12, p e792 (2021)
Background. Kidney transplantation and dialysis are two major risk factors for severe forms of coronavirus disease 2019 (COVID-19). The dynamics of the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in this population
Externí odkaz:
https://doaj.org/article/9036a2c630314485b4caca66a6375f22
Autor:
Mathilde Lemoine, Baptiste Dilly, Alexandre Curie, Vivien Hébert, Charlotte Laurent, Mélanie Hanoy, Steven Grangé, Dominique Guerrot, Arnaud François, Dominique Bertrand
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-5 (2019)
Abstract Background Immune Checkpoint Inhibitors (ICPIs) are promising new drugs in treatment of advanced tumours targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed cell death protein-1 (PD1) or its ligand (PDL-1). Ipilimumab is a mon
Externí odkaz:
https://doaj.org/article/b199096dd5e04e679dfb8ac608d2d03e